Throughout his career in the biopharmaceutical industry, Dean Tozer has demonstrated a keen business acumen and a proven history of product commercialization. He recently served as vice president of corporate development with Shire Regenerative Medicine, where he helped create one of the first global entities of its kind. Since accepting this role in 2011, Dean Tozer has developed a 10-year strategic plan and helped lead a $200 million therapeutics company that enhanced Shire’s range of offerings.
Dean Tozer came to Shire following a five-year tenure with Advanced BioHealing, Inc., where he led the acquisition, re-launch, and sale of a formerly distressed asset. Before accepting this position, he served as a commercialization consultant to a variety of clients via independent consultancy Tozer & Associates. He also commands eight years of experience with Searle Pharmaceuticals, a Monsanto company. There, he helped lead the record-breaking launch of Celebrex in the United States, as well as the drug’s world launch. Now focused on consulting and investing in start-up healthcare companies, Dean Tozer also serves as an Operating Partner in a growth equity investment fund.